These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26769703)

  • 21. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Singer DE; Albers GW; Dalen JE; Go AS; Halperin JL; Manning WJ
    Chest; 2004 Sep; 126(3 Suppl):429S-456S. PubMed ID: 15383480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anticoagulation and anti platelet therapy in patients with chronic kidney disease].
    Schirmer SH; Brandenburg V; Antlanger M
    Dtsch Med Wochenschr; 2019 Oct; 144(20):1423-1427. PubMed ID: 31594017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurologic Complications of Chronic Kidney Disease.
    Vellanki K; Bansal VK
    Curr Neurol Neurosci Rep; 2015 Aug; 15(8):50. PubMed ID: 26081561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Choice of Anticoagulant Therapy in Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease].
    Koziolova NA; Polyanskaya EA; Kolegova II
    Kardiologiia; 2017 Jan; (1):76-85. PubMed ID: 28290837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
    To AC; Yehia M; Collins JF
    Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
    Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
    Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. - Subanalysis of the J-RHYTHM Registry-.
    J-RHYTHM Registry Investigators
    Circ J; 2011; 75(10):2357-62. PubMed ID: 21791869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.
    Ng KP; Edwards NC; Lip GY; Townend JN; Ferro CJ
    Am J Kidney Dis; 2013 Sep; 62(3):615-32. PubMed ID: 23746378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease.
    Turagam MK; Addepally NS; Velagapudi P
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
    Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW
    Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Kalra PA; Burlacu A; Ferro CJ; Covic A
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.